Central Trust Company’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$579 Hold
7
– – ﹤0.01% 1517
2026
Q2
$672 Sell
7
-15
-68% -$1.54K ﹤0.01% 1519
2026
Q1
$2.4K Buy
22
+15
+214% +$1.43K ﹤0.01% 1350
2025
Q4
$568 Buy
+7
New +$603 ﹤0.01% 1431
2024
Q1
– Sell
-56
Closed -$3.18K – 1399
2023
Q4
$3.18K Hold
56
– – ﹤0.01% 1227
2023
Q3
$3.05K Hold
56
– – ﹤0.01% 1213
2023
Q2
$3.77K Hold
56
– – ﹤0.01% 1124
2023
Q1
$2.88K Hold
56
– – ﹤0.01% 1163
2022
Q4
$2.58K Hold
56
– – ﹤0.01% 1137
2022
Q3
$3K Hold
56
– – ﹤0.01% 1161
2022
Q2
$3K Hold
56
– – ﹤0.01% 1171
2022
Q1
$3K Buy
+56
New +$2.51K ﹤0.01% 1210

Other funds holding LMAT

Central Trust Company's LMAT Position: Q3 2026 in Review

Central Trust Company held its LeMaitre Vascular (LMAT) position steady in Q3 2026 at 7 shares worth $579. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Central Trust Company first reported a position in LMAT in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.77K in Q2 2023. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Central Trust Company held 7 shares of LeMaitre Vascular worth $579 as of Q3 2026.
  • Central Trust Company left its LeMaitre Vascular share count unchanged in Q3 2026.
  • LeMaitre Vascular made up ﹤0.01% of Central Trust Company's portfolio in Q3 2026, its #1517 holding.
  • Central Trust Company first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 12 quarters since.
  • Central Trust Company's LeMaitre Vascular position peaked at $3.77K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Central Trust Company's 13F filing for Q3 2026, filed 5 Nov 2026.